Tokyo Tape
Sign in
← ASKA Pharmaceutical Holdings

Annual report

4886.TEDINET S100OHVN
Period2021-04-01 → 2022-03-31
Filed2022-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 37
MetricValuePeriodScopeSource row
Revenue¥56.6bn2021-04-01 → 2022-03-31Cons.Net sales
Operating income¥4.8bn2021-04-01 → 2022-03-31Cons.Operating income
Ordinary income¥4.9bn2021-04-01 → 2022-03-31Cons.Ordinary income
Profit before tax¥6.2bn2021-04-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)¥4.3bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income¥4.3bn2021-04-01 → 2022-03-31Cons.Profit loss
Total assets¥83.3bnat 2022-03-31Cons.Assets
Total liabilities¥34.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥48.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥44.5bnat 2021-03-31Cons.Net assets
Cash and deposits¥12.1bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥17.1bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥10.5bnat 2021-03-31Cons.Cash and cash equivalents
Operating cash flow¥2.8bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities
Investing cash flow¥6.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥3.0bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥151.222021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
Net assets per share¥1,734.8at 2022-03-31Cons.Net assets per share (5-year summary)
Equity ratio58.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
ROE8.8%2021-04-01 → 2022-03-31Cons.Rate of return on equity (5-year summary)
Employees777at 2022-03-31Cons.Number of employees
Revenue¥1.4bn2021-04-01 → 2022-03-31StandaloneOperating revenue1
Operating income¥717m2021-04-01 → 2022-03-31StandaloneOperating income
Ordinary income¥717m2021-04-01 → 2022-03-31StandaloneOrdinary income
Profit before tax¥717m2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Net income¥682m2021-04-01 → 2022-03-31StandaloneProfit loss
Total assets¥41.3bnat 2022-03-31StandaloneAssets
Total liabilities¥606mat 2022-03-31StandaloneLiabilities
Net assets / equity¥40.7bnat 2022-03-31StandaloneNet assets
Cash and deposits¥820mat 2022-03-31StandaloneCash and deposits
EPS (basic)¥23.792021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥152021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Net assets per share¥1,443.94at 2022-03-31StandaloneNet assets per share (5-year summary)
Equity ratio98.5%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
ROE1.7%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
Shares issued30,563,199at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Employees74at 2022-03-31StandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2021-04-01 → 2022-03-31¥5m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2022-03-3148 pure
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2022-03-31¥5.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2022-03-31¥5.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2022-03-31¥73m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2022-03-31¥3.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2022-03-31¥360m
Reconciling Itemsreconcilingdepreciation2021-04-01 → 2022-03-31¥136m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2022-03-31−¥73m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2022-03-31−¥73m
Reconciling Itemsreconcilingsegment assetsat 2022-03-31¥37.3bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2022-03-31−¥653m
Pharmaceutical Businessreportable segmentdepreciation2021-04-01 → 2022-03-31¥2.5bn
Pharmaceutical Businessreportable segmentemployeesat 2022-03-31649 pure
Pharmaceutical Businessreportable segmentrevenue2021-04-01 → 2022-03-31¥50.8bn
Pharmaceutical Businessreportable segmentrevenue external2021-04-01 → 2022-03-31¥50.8bn
Pharmaceutical Businessreportable segmentsegment assetsat 2022-03-31¥42.9bn
Pharmaceutical Businessreportable segmentsegment profit2021-04-01 → 2022-03-31¥5.1bn
Total Of Reportable Segments And Otherssegment totaldepreciation2021-04-01 → 2022-03-31¥2.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2022-03-31¥56.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2022-03-31¥56.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2022-03-31¥73m
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2022-03-31¥46.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2022-03-31¥5.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,041
ItemContextValueUnit
Dividends income noiCurrentYearDuration258000000JPY
Other noiCurrentYearDuration120000000JPY
Non operating incomeCurrentYearDuration379000000JPY
Interest expenses noeCurrentYearDuration56000000JPY
Loss on disposal of noncurrent assets noeCurrentYearDuration43000000JPY
Expenses of inactive non current assets noeCurrentYearDuration155000000JPY
Other noeCurrentYearDuration38000000JPY
Non operating expensesCurrentYearDuration294000000JPY
Ordinary incomeCurrentYearDuration4880000000JPY
Gain on sales of noncurrent assets eiCurrentYearDuration9425000000JPY
Other eiCurrentYearDuration258000000JPY
Extraordinary incomeCurrentYearDuration9683000000JPY
Impairment loss elCurrentYearDuration5953000000JPY
Loss on valuation of investment securities elCurrentYearDuration1151000000JPY
Contract termination fees elCurrentYearDuration870000000JPY
Other elCurrentYearDuration425000000JPY
Extraordinary lossCurrentYearDuration8400000000JPY
Income before income taxesCurrentYearDuration6163000000JPY
Income taxes currentCurrentYearDuration983000000JPY
Income taxes deferredCurrentYearDuration890000000JPY
Income taxesCurrentYearDuration1873000000JPY
Profit lossCurrentYearDuration4290000000JPY
Profit loss attributable to owners of parentCurrentYearDuration4290000000JPY
Profit lossCurrentYearDuration4290000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYearDuration406000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYearDuration121000000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYearDuration164000000JPY
Other comprehensive incomeCurrentYearDuration692000000JPY
Comprehensive incomeCurrentYearDuration4982000000JPY
Comprehensive income attributable to owners of the parentCurrentYearDuration4982000000JPY
Net assetsPrior1YearInstant_CapitalStockMember1197000000JPY
Net assetsPrior1YearInstant_CapitalSurplusMember928000000JPY
Net assetsPrior1YearInstant_RetainedEarningsMember41790000000JPY
Net assetsPrior1YearInstant_TreasuryStockMember-2139000000JPY
Net assetsPrior1YearInstant_ShareholdersEquityMember41777000000JPY
Increase decrease by share transfersCurrentYearDuration_CapitalSurplusMember1165000000JPY
Increase decrease by share transfersCurrentYearDuration_TreasuryStockMember-1165000000JPY
Increase decrease by share transfersCurrentYearDuration_ShareholdersEquityMember－JPY
Dividends from surplusCurrentYearDuration_CapitalSurplusMember-199000000JPY
Dividends from surplusCurrentYearDuration_RetainedEarningsMember-199000000JPY
Dividends from surplusCurrentYearDuration_ShareholdersEquityMember-398000000JPY
Profit loss attributable to owners of parentCurrentYearDuration_RetainedEarningsMember4290000000JPY
Profit loss attributable to owners of parentCurrentYearDuration_ShareholdersEquityMember4290000000JPY
Purchase of treasury stockCurrentYearDuration_TreasuryStockMember-318000000JPY
Purchase of treasury stockCurrentYearDuration_ShareholdersEquityMember-318000000JPY
Disposal of treasury stockCurrentYearDuration_CapitalSurplusMember-27000000JPY
Disposal of treasury stockCurrentYearDuration_TreasuryStockMember144000000JPY
Disposal of treasury stockCurrentYearDuration_ShareholdersEquityMember117000000JPY
Change of scope of equity methodCurrentYearDuration_RetainedEarningsMember-47000000JPY
Change of scope of equity methodCurrentYearDuration_ShareholdersEquityMember-47000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identitynon_consolidated 2022-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass